|
KR20100028218A
|
|
Process for preparing synthetic intermediates of penem or carbapenem antibiotics
|
|
KR20090105107A
|
|
Process for preparing nitrobenzyl (1r,5r,6s)-6-(1r,5r,6s)-6-[(1r)-1-hydroxyethyl]-2-[(diphenylphosphono)oxyl]-1-methylcarbapen-2-em-3-carboxylate
|
|
KR20090105105A
|
|
Process for preparing a synthetic intermediate of carbapenems
|
|
EP2121739A1
|
|
Novel polypeptide having anti-tumor activity
|
|
US2010138941A1
|
|
Method for screening immune modulator
|
|
KR20070080355A
|
|
Pharmaceutical composition for prevention and treatment of hepatitis c virus-mediated liver disease
|
|
MX2008009493A
|
|
Novel peptide and use thereof.
|
|
KR20040050060A
|
|
An intermediate of an optically active diarylalanine, its derivatives and process for prepararing the same
|
|
KR20050022745A
|
|
Processes for the preparation of an optically active 5,6-dioxopiperazine-2-carboxylic acid derivative
|
|
KR20050011310A
|
|
A process for preparing an optically pure 2-amino-1,3-diol or 2-amino-3-ol derivative
|
|
KR20040090065A
|
|
A oxazolidinone derivative, a process for the preparation thereof, and a composition comprising the same
|
|
WO2004062687A1
|
|
Pharmaceutical composition for cancer treatment containing p43 protein and paclitaxel, therapy method using the same and use thereof
|
|
KR100405918B1
|
|
Pharmaceutical composition for treatment of cancer containing p43 protein and paclitaxel
|
|
KR20040063512A
|
|
Aminoacyl adenylate mimics having antimicrobial and antiparasitic activity and the pharmaceutical composition comprising the same
|
|
KR20040037723A
|
|
The process for preparing itraconazole intermediate
|
|
KR20030080675A
|
|
Rna specifically binding to nfatc
|
|
KR20030063813A
|
|
An intermediate of an optically active diarylalanine, its derivatives and process for prepararing the same
|
|
US7268228B2
|
|
Optically active aziridine-2-carboxylate derivatives and a process for preparing them
|
|
KR20020092596A
|
|
Immunological enhancement agent comprising N-terminal peptide of p43 as an effective component
|
|
WO0195927A1
|
|
P43 anti-tumor therapeutic agent and three dimensional structure of its cytokine domain
|
